Physician
Pediatrics and Adolescent Medicine, P.C.
Pediatrics and Adolescent Medicine, P.C. was paid $2.38M by Medicaid between Jan 2018 and Apr 2023, across 51 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoPEDIATRICS AND ADOLESCENT MEDICINE, P.C.
DES MOINES, IA 50312
DES MOINES, IA 50312
33aNPI1134259427assigned 03/06/2007
33bProvider typeDevelopmental - Behavioral Pediatrics Physician
28Total paid$2.38M
24GClaims74,013
24DCodes billed51
24AFirst – last monthJan 2018 – Apr 2023
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,927 | $422K | |
| 2019 | 17,753 | $459K | |
| 2020 | 13,968 | $344K | |
| 2021 | 14,717 | $562K | |
| 2022 | 11,097 | $495K | |
| 2023 | 2,551 | $103K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 18,423 | 12,881 | $623K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 18% | 4,760 | 3,702 | $434K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 10.0% | 5,435 | 4,455 | $237K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 8.1% | 5,147 | 3,825 | $192K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.6% | 2,690 | 1,982 | $133K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.3% | 2,700 | 2,410 | $128K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.2% | 1,963 | 1,637 | $124K |
| 87634 | 4.9% | 1,764 | 1,365 | $118K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.8% | 1,464 | 1,199 | $91K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 1,627 | 1,221 | $87K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.8% | 909 | 770 | $67K |
| 83655 | 1.1% | 1,968 | 1,599 | $26K |
39 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,290 | $19K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,395 | $18K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,086 | $16K |
| 80061 | Lipid panel | <1% | 618 | $11K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 118 | $10K |
| 85013 | <1% | 2,970 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 178 | $6K |
| 86328 | <1% | 142 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 115 | $5K |
| 90651 | <1% | 459 | $3K | |
| 90688 | <1% | 1,397 | $3K | |
| 90670 | <1% | 1,386 | $2K | |
| 90734 | <1% | 359 | $2K | |
| 90716 | <1% | 567 | $2K | |
| 87088 | <1% | 179 | $2K | |
| 87071 | <1% | 280 | $2K | |
| 90707 | <1% | 578 | $1K | |
| 81003 | <1% | 681 | $1K | |
| 0071A | <1% | 35 | $1K | |
| 90620 | <1% | 118 | $995.37 | |
| 0072A | <1% | 24 | $960.00 | |
| 90713 | <1% | 1,560 | $880.71 | |
| 90700 | <1% | 1,915 | $715.72 | |
| 90633 | <1% | 412 | $481.45 | |
| 90715 | <1% | 184 | $464.05 | |
| 90648 | <1% | 1,407 | $402.72 | |
| 86710 | <1% | 15 | $385.40 | |
| 90744 | <1% | 410 | $350.00 | |
| 87899 | <1% | 20 | $272.64 | |
| 87070 | <1% | 21 | $244.80 | |
| 86308 | <1% | 30 | $198.45 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,207 | $188.61 |
| 90687 | <1% | 457 | $167.30 | |
| 90680 | <1% | 364 | $160.14 | |
| 85027 | <1% | 24 | $147.06 | |
| 99000 | <1% | 61 | $85.59 | |
| 99072 | 0% | 1,975 | $0.00 | |
| 90658 | 0% | 17 | $0.00 | |
| 91307 | 0% | 109 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALDRICH, FREDERICK (PRESIDENT)